Literature DB >> 11193789

A perspective on inflammation in Alzheimer's disease.

J Rogers1, Y Shen.   

Abstract

Although there have been hundreds of recent papers that document a role for innate inflammatory responses in Alzheimer's disease (AD), several global issues and organizational points are still worth emphasizing. These include etiologic versus pathogenic roles for AD inflammation, the potency of AD inflammation, the sources of AD inflammation, and the highly interactive nature of AD inflammatory responses.

Entities:  

Mesh:

Year:  2000        PMID: 11193789     DOI: 10.1111/j.1749-6632.2000.tb05571.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  22 in total

Review 1.  The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment.

Authors:  G Stennis Watson; Suzanne Craft
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 2.  Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?

Authors:  Kawser Akter; Emily A Lanza; Stephen A Martin; Natalie Myronyuk; Melanie Rua; Robert B Raffa
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

Review 3.  The role of inflammatory processes in Alzheimer's disease.

Authors:  G Joseph Broussard; Jennifer Mytar; Rung-chi Li; Gloria J Klapstein
Journal:  Inflammopharmacology       Date:  2012-04-26       Impact factor: 4.473

Review 4.  Type 2 diabetes and cognitive compromise: potential roles of diabetes-related therapies.

Authors:  Efrat Kravitz; James Schmeidler; Michal Schnaider Beeri
Journal:  Endocrinol Metab Clin North Am       Date:  2013-09       Impact factor: 4.741

5.  Gangliosides play pivotal roles in the regulation of complement systems and in the maintenance of integrity in nerve tissues.

Authors:  Yuhsuke Ohmi; Orie Tajima; Yuki Ohkawa; Atsushi Mori; Yasuo Sugiura; Keiko Furukawa; Koichi Furukawa
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-11       Impact factor: 11.205

6.  Pro-neurogenic effect of β-asarone on RSC96 Schwann cells in vitro.

Authors:  Fuben Xu; Huayu Wu; Kun Zhang; Peizhen Lv; Li Zheng; Jinmin Zhao
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-12-10       Impact factor: 2.416

7.  Gain in brain immunity in the oldest-old differentiates cognitively normal from demented individuals.

Authors:  Pavel Katsel; Weilun Tan; Vahram Haroutunian
Journal:  PLoS One       Date:  2009-10-29       Impact factor: 3.240

8.  Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy.

Authors:  Elina Zotova; James Ar Nicoll; Raj Kalaria; Clive Holmes; Delphine Boche
Journal:  Alzheimers Res Ther       Date:  2010-01-22       Impact factor: 6.982

9.  NSAIDs may protect against age-related brain atrophy.

Authors:  Barbara B Bendlin; Lisa M Newman; Michele L Ries; Luigi Puglielli; Cynthia M Carlsson; Mark A Sager; Howard A Rowley; Catherine L Gallagher; Auriel A Willette; Andrew L Alexander; Sanjay Asthana; Sterling C Johnson
Journal:  Front Aging Neurosci       Date:  2010-09-03       Impact factor: 5.750

10.  Neuroinflammation, microglia and implications for anti-inflammatory treatment in Alzheimer's disease.

Authors:  Daniela L Krause; Norbert Müller
Journal:  Int J Alzheimers Dis       Date:  2010-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.